HUP0201262A3 - Process for preparing [s-(r*,s*)]-betha-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivatives - Google Patents

Process for preparing [s-(r*,s*)]-betha-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivatives

Info

Publication number
HUP0201262A3
HUP0201262A3 HU0201262A HUP0201262A HUP0201262A3 HU P0201262 A3 HUP0201262 A3 HU P0201262A3 HU 0201262 A HU0201262 A HU 0201262A HU P0201262 A HUP0201262 A HU P0201262A HU P0201262 A3 HUP0201262 A3 HU P0201262A3
Authority
HU
Hungary
Prior art keywords
piperidinyl
betha
oxo
carbonyl
propyl
Prior art date
Application number
HU0201262A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of HU0201262D0 publication Critical patent/HU0201262D0/hu
Publication of HUP0201262A2 publication Critical patent/HUP0201262A2/hu
Publication of HUP0201262A3 publication Critical patent/HUP0201262A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HU0201262A 1999-03-22 2000-03-21 Process for preparing [s-(r*,s*)]-betha-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivatives HUP0201262A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12567199P 1999-03-22 1999-03-22

Publications (3)

Publication Number Publication Date
HU0201262D0 HU0201262D0 (cg-RX-API-DMAC7.html) 2002-05-29
HUP0201262A2 HUP0201262A2 (en) 2002-08-28
HUP0201262A3 true HUP0201262A3 (en) 2003-12-29

Family

ID=22420863

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201262A HUP0201262A3 (en) 1999-03-22 2000-03-21 Process for preparing [s-(r*,s*)]-betha-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivatives

Country Status (22)

Country Link
US (2) US6515130B1 (cg-RX-API-DMAC7.html)
EP (1) EP1165543B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002540108A (cg-RX-API-DMAC7.html)
KR (1) KR20020019895A (cg-RX-API-DMAC7.html)
CN (1) CN1351600A (cg-RX-API-DMAC7.html)
AT (1) ATE242235T1 (cg-RX-API-DMAC7.html)
AU (1) AU775413B2 (cg-RX-API-DMAC7.html)
BR (1) BR0010652A (cg-RX-API-DMAC7.html)
CA (1) CA2368024A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20013431A3 (cg-RX-API-DMAC7.html)
DE (1) DE60003169T2 (cg-RX-API-DMAC7.html)
DK (1) DK1165543T3 (cg-RX-API-DMAC7.html)
ES (1) ES2199805T3 (cg-RX-API-DMAC7.html)
HK (1) HK1046272A1 (cg-RX-API-DMAC7.html)
HR (1) HRP20010767A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0201262A3 (cg-RX-API-DMAC7.html)
MX (1) MXPA01009615A (cg-RX-API-DMAC7.html)
PT (1) PT1165543E (cg-RX-API-DMAC7.html)
SK (1) SK13562001A3 (cg-RX-API-DMAC7.html)
UA (1) UA67832C2 (cg-RX-API-DMAC7.html)
WO (1) WO2000056730A1 (cg-RX-API-DMAC7.html)
YU (1) YU74601A (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002540101A (ja) 1999-03-22 2002-11-26 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド プロピオン酸３−アミノ−３−アリールの合成
SI1430057T1 (sl) * 2001-09-21 2006-02-28 Sanofi Aventis Substituirani 2-piridinil-6,7,8,9-tetrahidropirimido -(1,2-a)pirimidin-4-onski in 7-piridinil-2,3-dihidroimidazo -(1,2-a)pirimidin-5(1H)onski derivati
DK2744802T3 (en) 2011-08-17 2017-04-03 Piramal Imaging Sa CONNECTIONS FOR BINDING TO THE TROMBOCYTE SPECIFIC GLYCOPROTEIN IIB / IIIA AND ITS APPLICATION FOR IMAGE DIAGNOSIS OF TROMBER
WO2014124943A1 (en) 2013-02-12 2014-08-21 Bayer Pharma Aktiengesellschaft Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia
ES2777200T3 (es) 2013-02-20 2020-08-04 Reuter Chemische Apparatenbau Ek Procedimiento para la preparación de 3-aminopiperidina enriquecida enantioméricamente
WO2014173855A1 (en) 2013-04-22 2014-10-30 Reuter Chemische Apparatebau Kg Process for preparing enantiomerically enriched 3-hydroxymethylpiperidine
KR102548998B1 (ko) 2020-03-31 2023-06-29 재단법인 아산사회복지재단 혈전영상을 위한 방사성의약품 및 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58243B1 (en) 1983-12-07 1993-08-11 Lonza Ag A process for the preparation of optically-active 3-amino carboxylic acids
US5254573A (en) 1991-10-15 1993-10-19 Monsanto Company Substituted heterocyclic derivatives useful as platelet aggregation inhibitors
DK0669912T3 (da) * 1993-09-22 2002-03-04 Fujisawa Pharmaceutical Co N-(3-Piperidinylcarbonyl)-beta-alaninderivater som PAF-antagonister
US5770575A (en) * 1994-03-16 1998-06-23 Ortho Pharmaceutical Corporation Nipecotic acid derivatives as antithrombotic compounds
EP0888302A1 (en) * 1996-03-13 1999-01-07 Fujisawa Pharmaceutical Co., Ltd. N- (r)-1- 3-(4-piperidyl)propionyl-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist
RU2194038C2 (ru) * 1996-05-01 2002-12-10 Орто-Макнейл Фармасьютикал, Инк. Карбоксамидные производные пирролидина или пиперидина, фармацевтическая композиция на их основе и способ ингибирования агрегации тромбоцитов
ATE209179T1 (de) 1996-07-12 2001-12-15 Searle & Co Asymmetrische synthese von chiralen beta- aminosäuren
US6066651A (en) * 1997-10-29 2000-05-23 Ortho-Mcneil Pharmaceutical, Inc. Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders

Also Published As

Publication number Publication date
WO2000056730A1 (en) 2000-09-28
MXPA01009615A (es) 2003-07-21
DE60003169T2 (de) 2005-10-27
ES2199805T3 (es) 2004-03-01
HRP20010767A2 (en) 2002-12-31
AU3766100A (en) 2000-10-09
CZ20013431A3 (cs) 2003-04-16
JP2002540108A (ja) 2002-11-26
EP1165543A1 (en) 2002-01-02
HUP0201262A2 (en) 2002-08-28
CN1351600A (zh) 2002-05-29
KR20020019895A (ko) 2002-03-13
YU74601A (sh) 2004-05-12
UA67832C2 (uk) 2004-07-15
US20020137937A1 (en) 2002-09-26
AU775413B2 (en) 2004-07-29
EP1165543B1 (en) 2003-06-04
SK13562001A3 (sk) 2002-08-06
ATE242235T1 (de) 2003-06-15
US6515130B1 (en) 2003-02-04
DK1165543T3 (da) 2003-09-29
HK1046272A1 (zh) 2003-01-03
CA2368024A1 (en) 2000-09-28
DE60003169D1 (de) 2003-07-10
PT1165543E (pt) 2003-10-31
BR0010652A (pt) 2002-07-16
HU0201262D0 (cg-RX-API-DMAC7.html) 2002-05-29

Similar Documents

Publication Publication Date Title
HUP0200748A3 (en) Process for preparing amine platinum complexes
HUP0203206A3 (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
IL126264A0 (en) Process for preparing lactic acid
DE50003632D1 (de) Verfahren zur herstellung von l-phenylephrinhydrochlorid
HUP0100760A3 (en) 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0103835A3 (en) Method for preparing alkoxyamines from nitroxides
AU9038601A (en) Process for making cheese containing gum
IL144697A0 (en) Microbial process for preparing paravastatin
HUP0004884A3 (en) Process for preparing 1,4-dihydropyridine derivatives
HUP0201262A3 (en) Process for preparing [s-(r*,s*)]-betha-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivatives
HUP0203159A3 (en) Method for producing liposome preparation, containing pipecolic acid derivative
SI1216226T1 (sl) Postopek za pripravo derivatov fenilocetne kisline
HUP0003861A3 (en) Quinolin-4-yl derivatives, process for producing them and pharmaceutical compositions containing them
TWI318213B (en) Polyamide nucleic acid derivatives, and agents and processes for preparing them
IL158660A0 (en) Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
HU0000907D0 (en) Process for preparing growth hormone secretagagues
HUP0201418A3 (en) Process for preparing r-(-)-carnitine from s-(-)-chlorosuccinic acid or from a derative thereof
HUP0201281A3 (en) (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
SG83788A1 (en) Method for preparing polymer
AU2003286843A8 (en) Process for preparing hybrid proteins
HUP0200342A3 (en) Novel process for preparing alendronic acid
HUP0202200A3 (en) Antipsychotic cyclic n-aralkyl amines, process for producing them and pharmaceutical compositions containing them
HUP0103778A3 (en) Process for preparing 1,5-diaryl-3-substituted pyrazoles
SI1165543T1 (en) PROCESS FOR PREPARING S-(R*,S*)) -$g(b) - 1- 1-OXO-3- (4-PIPERIDINYL) PROPYL) -3-PIPERIDINYL) CARBONYL) AMINO) -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES
PL350362A1 (en) Processes for preparing optically active amino acid derivatives